Scholarly Index
Won Seog Kim
Seoul Medical Center; 19,469 total citations; 668 total publications; best world rank #24
Seoul Medical Center
19,469Total citations
668Total publications
63H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Lymphoma Diagnosis and Treatment | Lifetime | 278 | KR 2 | 99.18 |
| Viral-associated cancers and disorders | Lifetime | 201 | KR 2 | 98.72 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 568 | KR 4 | 98.52 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 117 | KR 1 | 98.30 |
| CAR-T cell therapy research | Lifetime | 670 | KR 2 | 98.18 |
| T-cell and Retrovirus Studies | Lifetime | 233 | KR 1 | 97.50 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 277 | KR 2 | 97.24 |
| Biosimilars and Bioanalytical Methods | Lifetime | 602 | KR 15 | 91.83 |
| Vascular Tumors and Angiosarcomas | Lifetime | 697 | KR 5 | 92.35 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 62 | KR 1 | 99.24 |
| Viral-associated cancers and disorders | 2021-2025 | 24 | KR 1 | 98.24 |
| CAR-T cell therapy research | 2021-2025 | 201 | KR 1 | 98.53 |
| CNS Lymphoma Diagnosis and Treatment | 2021-2025 | 33 | KR 1 | 97.79 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 204 | KR 3 | 97.62 |
| T-cell and Retrovirus Studies | 2021-2025 | 51 | KR 1 | 94.11 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 123 | KR 1 | 94.28 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 246 | KR 4 | 88.65 |